Results 41 to 50 of about 1,653,509 (288)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer

open access: yesBiomedicines, 2021
Approximately 19% of all cancer-related deaths are due to lung cancer, which is the leading cause of mortality worldwide. Small cell lung cancer (SCLC) affects approximately 15% of patients diagnosed with lung cancer.
Patricia Mondelo-Macía   +6 more
doaj   +1 more source

Liquid biopsy from research to clinical practice : focus on non-small cell lung cancer

open access: yes, 2021
: Introduction In the current era of personalized medicine, liquid biopsy has acquired a relevant importance in patient management of advanced stage non-small cell lung cancer (NSCLC).
Pisapia, Pasquale   +20 more
core  

Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy

open access: yes, 2023
Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major advancement toward the early detection of cancer. In comparison to tissue biopsy techniques, liquid biopsy is relatively painless, offering multiple sampling opportunities ...
Nguyen, Nam-Trung   +11 more
core   +1 more source

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation

open access: yesJournal for ImmunoTherapy of Cancer, 2022
Cancer-related deaths are mainly caused by metastatic spread of tumor cells from the primary lesion to distant sites via the blood circulation.
Klaus Pantel, Catherine Alix-Panabières
doaj   +1 more source

Endoscopic Trans-Mini-Cylinder Biopsy for Intraparenchymal Brain Lesions [PDF]

open access: yes, 2022
Objective: The biopsy procedure is intended to obtain an adequate specimen volume from the targeted area while ensuring minimal damage to the normal brain.
Yuichi Nagata   +21 more
core   +1 more source

Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

open access: yesBreast Cancer Research, 2019
Background Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of patients who eventually develop distal disease, not detectable by current methods.
Alba Rodríguez-Martínez   +13 more
doaj   +1 more source

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype

open access: yesFrontiers in Cell and Developmental Biology, 2023
Metastatic progression is the deadliest feature of cancer. Cancer cell growth, invasion, intravasation, circulation, arrest/adhesion and extravasation require specific mechanical properties to allow cell survival and the completion of the metastatic ...
Keerthi Kurma   +5 more
doaj   +1 more source

Liquid biopsy: a right tool in a right context?

open access: yes, 2022
Liquid biopsy is a minimally or noninvasive technique for finding that circulates tumor components in biofluids. Generally, blood is used but any biological fluid can be used such as urine, pleural effusion, and saliva.
Incorvaia L.   +10 more
core   +1 more source

Tyrosine Kinase Inhibitors Could Be Effective Against Non-small Cell Lung Cancer Brain Metastases Harboring Uncommon EGFR Mutations

open access: yesFrontiers in Oncology, 2020
Background: The significance of uncommon epidermal growth factor receptor (EGFR) mutations in patients with non-small cell lung cancer (NSCLC) and brain metastasis (BM) remains unclear.
Chunhua Ma   +15 more
doaj   +1 more source

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

open access: yesFrontiers in Oncology, 2021
BackgroundLung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm.
Maosong Ye   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy